New approach for estimating risk of miscarriage after chorionic villus sampling

To estimate the risk of miscarriage associated with chorionic villus sampling (CVS).

[1]  R. Akolekar,et al.  Procedure‐related risk of miscarriage following chorionic villus sampling and amniocentesis , 2019, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[2]  L. Salomon,et al.  Risk of miscarriage following amniocentesis or chorionic villus sampling: systematic review of literature and updated meta‐analysis , 2019, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[3]  K. Navaratnam,et al.  Trials and tribulations of meta‐analyzing procedure‐related risks of amniocentesis and chorionic villus sampling , 2019, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[4]  J. Jais,et al.  Effect of Cell-Free DNA Screening vs Direct Invasive Diagnosis on Miscarriage Rates in Women With Pregnancies at High Risk of Trisomy 21: A Randomized Clinical Trial , 2018, JAMA.

[5]  Zarko Alfirevic,et al.  Amniocentesis and chorionic villus sampling for prenatal diagnosis. , 2017, The Cochrane database of systematic reviews.

[6]  T. Hagobian,et al.  Total pregnancy loss after chorionic villus sampling and amniocentesis: a cohort study , 2017, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[7]  D. Sahota,et al.  Procedure-Related Fetal Loss following Chorionic Villus Sampling after First-Trimester Aneuploidy Screening , 2016, Fetal Diagnosis and Therapy.

[8]  T. Gerds,et al.  Risk of fetal loss associated with invasive testing following combined first‐trimester screening for Down syndrome: a national cohort of 147 987 singleton pregnancies , 2016, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[9]  D. Wright,et al.  First-Trimester Screening for Trisomies 21, 18 and 13 by Ultrasound and Biochemical Testing , 2013, Fetal Diagnosis and Therapy.

[10]  K. Nicolaides,et al.  Prediction of miscarriage and stillbirth at 11–13 weeks and the contribution of chorionic villus sampling , 2011, Prenatal diagnosis.

[11]  P. Austin,et al.  Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies , 2010, Pharmaceutical statistics.

[12]  G. Macones,et al.  Evaluating the Rate and Risk Factors for Fetal Loss After Chorionic Villus Sampling , 2008, Obstetrics and gynecology.

[13]  I. Staboulidou,et al.  Screening for Adverse Pregnancy Outcome by Ductus Venosus Doppler at 11–13+6 Weeks of Gestation , 2008, Obstetrics and gynecology.

[14]  Gary King,et al.  Matching as Nonparametric Preprocessing for Reducing Model Dependence in Parametric Causal Inference , 2007, Political Analysis.

[15]  K. Nicolaides,et al.  First‐trimester ultrasound and biochemical markers of aneuploidy and the prediction of impending fetal death , 2006, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[16]  Til Stürmer,et al.  Indications for propensity scores and review of their use in pharmacoepidemiology. , 2006, Basic & clinical pharmacology & toxicology.

[17]  Søren Højsgaard,et al.  The R Package geepack for Generalized Estimating Equations , 2005 .

[18]  Peter C Austin,et al.  Propensity score methods gave similar results to traditional regression modeling in observational studies: a systematic review. , 2005, Journal of clinical epidemiology.

[19]  K. Nicolaides,et al.  Increased nuchal translucency with normal karyotype. , 2005, American journal of obstetrics and gynecology.

[20]  K. Nicolaides,et al.  Outcome of pregnancy in chromosomally normal fetuses with increased nuchal translucency in the first trimester , 2001, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[21]  C. Lundsteen,et al.  Randomised study of risk of fetal loss related to early amniocentesis versus chorionic villus sampling , 1997, The Lancet.

[22]  K. Nicolaides,et al.  Comparison of chorionic villus sampling and amniocentesis for fetal karyotyping at 10-13 weeks' gestation , 1994, The Lancet.

[23]  D. Ledbetter,et al.  A randomized comparison of transcervical and transabdominal chorionic-villus sampling. The U.S. National Institute of Child Health and Human Development Chorionic-Villus Sampling and Amniocentesis Study Group. , 1992, The New England journal of medicine.

[24]  Annex 1: The Canadian collaborative CVS‐amniocentesis clinical trial group , 1992 .

[25]  I. Chalmers,et al.  Medical Research Council European Trial of chorion villus sampling , 1991, The Lancet.

[26]  C4591001 Clinical Trial Group.  MULTICENTRE RANDOMISED CLINICAL TRIAL OF CHORION VILLUS SAMPLING AND AMNIOCENTESIS First Report , 1989, The Lancet.

[27]  Ann Tabor,et al.  RANDOMISED CONTROLLED TRIAL OF GENETIC AMNIOCENTESIS IN 4606 LOW-RISK WOMEN , 1986, The Lancet.

[28]  H. Wallenburg,et al.  LOW-DOSE ASPIRIN PREVENTS PREGNANCY-INDUCED HYPERTENSION AND PRE-ECLAMPSIA IN ANGIOTENSIN-SENSITIVE PRIMIGRAVIDAE , 1986, The Lancet.

[29]  J. Fleming,et al.  A CRITICAL EVALUATION OF SONAR “CROWN‐RUMP LENGTH” MEASUREMENTS , 1975, British journal of obstetrics and gynaecology.

[30]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .